Metoclopramide Hydrochloride Anhydrous Noridem (Metoclopramide Hydrochloride Monohydrate)

Metoclopramide works by blocking dopamine D2 receptors in the chemoreceptor trigger zone of the brain, which reduces the sensation of nausea. In the gastrointestinal tract it stimulates motility, helping the stomach empty more quickly, and it also has weak antagonism of 5‑HT3 receptors and anticholinergic activity that further support its anti‑nausea effect.

The specific dose and frequency of metoclopramide are determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. Healthcare professionals should follow local prescribing guidelines and adjust the regimen as needed.

Safety data for metoclopramide in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any potential risk to the fetus. Metoclopramide is excreted in breast milk, so caution is advised for nursing mothers, and alternative therapies should be considered when possible.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if required) and necessary import documentation.

Metoclopramide differs from many antiemetics such as ondansetron, which primarily blocks serotonin receptors. Metoclopramide’s dopamine antagonism and pro‑kinetic activity make it useful for both nausea control and enhancing gastric emptying, whereas drugs like ondansetron lack pro‑kinetic effects. Choice of therapy depends on the clinical scenario, patient tolerance, and drug‑interaction profile.

Metoclopramide Hydrochloride Anhydrous Noridem should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. The product should remain in its original packaging until ready for use to maintain sterility and potency.

The medication is supplied as an injectable solution for intramuscular or intravenous administration. The route, rate of infusion, and volume are determined by the prescribing clinician, who will follow aseptic technique and appropriate dilution guidelines as per local practice.

Serious risks include extrapyramidal reactions such as acute dystonia, tardive dyskinesia with long‑term use, neuroleptic malignant syndrome, and severe allergic reactions like anaphylaxis. Patients should be monitored closely for any signs of involuntary movements, fever, rigidity, or hypersensitivity, and the drug should be discontinued immediately if these occur.

Metoclopramide is contraindicated in individuals with known hypersensitivity to the drug, in patients with pheochromocytoma, and in those with a history of severe extrapyramidal reactions. Caution is also advised for patients with gastrointestinal obstruction, perforation, or hemorrhage, as the pro‑kinetic effect could worsen these conditions.